These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11513896)

  • 1. Characterisation of a beta-tubulin gene from the liver fluke, Fasciola hepatica.
    Robinson MW; Hoey EM; Fairweather I; Dalton JP; McGonigle S; Trudgett A
    Int J Parasitol; 2001 Sep; 31(11):1264-8. PubMed ID: 11513896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitology; 2002 Mar; 124(Pt 3):325-38. PubMed ID: 11922434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes.
    Ryan LA; Hoey E; Trudgett A; Fairweather I; Fuchs M; Robinson MW; Chambers E; Timson DJ; Ryan E; Feltwell T; Ivens A; Bentley G; Johnston D
    Mol Biochem Parasitol; 2008 May; 159(1):73-8. PubMed ID: 18372053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of liver fluke β-tubulin isotypes at selected life cycle stages.
    Fuchs MA; Ryan LA; Chambers EL; Moore CM; Fairweather I; Trudgett A; Timson DJ; Brennan GP; Hoey EM
    Int J Parasitol; 2013 Dec; 43(14):1133-9. PubMed ID: 24162076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica.
    Fetterer RH
    J Vet Pharmacol Ther; 1986 Mar; 9(1):49-54. PubMed ID: 3701915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T687G SNP in a P-glycoprotein gene of Fasciola hepatica is not associated with resistance to triclabendazole in two resistant Australian populations.
    Elliott TP; Spithill TW
    Mol Biochem Parasitol; 2014 Nov; 198(1):45-7. PubMed ID: 25481750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid substitution in isozyme GST mu in Triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance.
    Fernández V; Estein S; Ortiz P; Luchessi P; Solana V; Solana H
    Exp Parasitol; 2015 Dec; 159():274-9. PubMed ID: 26542261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Modelling and Molecular Docking Analysis of Fasciola hepatica β-Tubulin's Interaction Sites, with Triclabendazole, Triclabendazole Sulphoxide and Triclabendazole Sulphone.
    Olivares-Ferretti P; Beltrán JF; Salazar LA; Fonseca-Salamanca F
    Acta Parasitol; 2023 Sep; 68(3):535-547. PubMed ID: 37330945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica.
    Chemale G; Perally S; LaCourse EJ; Prescott MC; Jones LM; Ward D; Meaney M; Hoey E; Brennan GP; Fairweather I; Trudgett A; Brophy PM
    J Proteome Res; 2010 Oct; 9(10):4940-51. PubMed ID: 20726552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative markers of triclabendazole resistance by a genome-wide analysis of genetically recombinant Fasciola hepatica.
    Hodgkinson J; Cwiklinski K; Beesley NJ; Paterson S; Williams DJ
    Parasitology; 2013 Oct; 140(12):1523-33. PubMed ID: 23721579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement.
    Robinson MW; McFerran N; Trudgett A; Hoey L; Fairweather I
    J Mol Graph Model; 2004 Dec; 23(3):275-84. PubMed ID: 15530823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a novel panel of polymorphic microsatellite loci for the liver fluke, Fasciola hepatica, using a next generation sequencing approach.
    Cwiklinski K; Allen K; LaCourse J; Williams DJ; Paterson S; Hodgkinson JE
    Infect Genet Evol; 2015 Jun; 32():298-304. PubMed ID: 25796359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of triclabendazole resistance in liver fluke in the UK.
    Gordon D; Zadoks R; Skuce P; Sargison N
    Vet Rec; 2012 Aug; 171(6):159-60. PubMed ID: 22890401
    [No Abstract]   [Full Text] [Related]  

  • 20. Triclabendazole-resistant liver fluke in Scottish sheep.
    Mitchell GB; Maris L; Bonniwell MA
    Vet Rec; 1998 Oct; 143(14):399. PubMed ID: 9802201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.